Vivimed Labs has informed the stock exchanges of an upcoming Board of Directors meeting scheduled for Thursday, May 28, 2026, to be held at Hyderabad. The intimation, dated May 16, 2026, was filed pursuant to Regulation 29 of the SEBI (Listing Obligations & Disclosure Requirements), 2015.

Board Meeting Agenda

The primary purpose of the meeting is to consider and approve the audited financial results of the company for the quarter and year ending March 31, 2026. The Board will review both standalone and consolidated financial statements, in addition to any other items that may be placed before it.

Key details of the scheduled meeting are summarised below:

Regulatory Compliance

The notice was issued in accordance with Regulation 29 of the SEBI (Listing Obligations & Disclosure Requirements), 2015, which mandates listed companies to provide advance intimation to stock exchanges prior to board meetings where financial results are to be considered. The communication was signed by Yugandhar Kopparthi, Company Secretary of Vivimed Labs.

The National Company Law Tribunal, Bengaluru Bench has initiated corporate insolvency resolution proceedings against Vivimed Labs Limited on 15.04.2026, marking a significant development for the pharmaceutical company that has been operational since 1988.

Company Background and Insolvency Details

Vivimed Labs Limited, incorporated on 22.09.1988 under the Registrar of Companies, Bangalore, carries the Corporate Identity Number L02411KA1988PLC009465. The company maintains its registered office at Plot No. 78-A, Kothar Industrial Area, Bidar, Karnataka - 585403, with its corporate office located at GMR Towers, 3rd & 4th Floor, Green Lands, Begumpet, Beside the Plaza Hotel, Hyderabad, Telangana - 500016.

Interim Resolution Professional Appointment

T Narayana Swamy has been appointed as the interim resolution professional with IBBI Registration Number IBBI/IPA-002/IP-N01078/2020-2021/13427. His registered address is No. 15, Shubhadeepa, 7th Cross, Bhuvaneshwarinagar, Hebbal Kempapura, Bangalore North, Near Shakthi Ganapathi Temple, Bangalore, Karnataka - 560024.

For correspondence purposes, creditors should contact the interim resolution professional at "VK Commerce", # 8, 3rd Floor, 3rd Main Road, Opp. Rajajinagar IT Park, KSSIDC, Rajajinagar Industrial Estate, Bengaluru, Karnataka - 560010, with email communications directed to cirp.vivimedlabslimited@hotmail.com .

Claims Submission Process

Creditors of Vivimed Labs Limited must submit their claims with supporting proof by 01.05.2026. The submission process varies based on creditor type:

• Financial Creditors: Must submit claims electronically only
• Other Creditors: May submit claims in person, by post, or electronically

All relevant forms are available at the IBBI website ( https://ibbi.gov.in/en/home/downloads ). The announcement emphasizes that submission of false or misleading proofs of claim will attract penalties under applicable regulations.

Regulatory Framework

The proceedings are conducted under Regulation 6 of the Insolvency and Bankruptcy Board of India (Insolvency Resolution Process for Corporate Persons) Regulations, 2016. Currently, no specific classes of creditors have been identified under clause (b) of sub-section (6A) of section 21, and no insolvency professionals have been designated as authorized representatives for creditor classes.

The corporate insolvency resolution process represents a structured approach to address the company's financial distress while providing an opportunity for potential resolution or recovery for stakeholders. The six-month timeline provides a defined framework for creditors to participate in the resolution process and for potential buyers or investors to evaluate restructuring opportunities.